DUBLIN, Ireland, Sept. 06, 2016 (GLOBE NEWSWIRE) — Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will present at the Morgan Stanley Global Healthcare Conference at 9:20 a.m. ET on September 12, 2016 in New York City, NY.
The conference presentation, which will include an update of Horizon’s business, will be webcast live and may be accessed by visiting Horizon’s investor relations section of the website at http://ir.horizon-pharma.com. A replay of the webcast will be available for the event.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
CONTACT: Contacts: Investors: John Thomas Executive Vice President, Strategy and Investor Relations email@example.com Tina Ventura Vice President, Investor Relations firstname.lastname@example.org U.S. Media: Geoff Curtis Senior Vice President, Corporate Communications email@example.com Ireland Media: Ray Gordon Gordon MRM firstname.lastname@example.org